1. Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
   Kyung-Soo Kim et al, 2020, Clinical and Molecular Hepatology CrossRef
2. Apigenin Attenuates Acetaminophen-Induced Hepatotoxicity by Activating AMP-Activated Protein Kinase/Carnitine Palmitoyltransferase I Pathway
   Jiaqi Zhang et al, 2020, Frontiers in Pharmacology CrossRef
3. LRRK2 Regulates CPT1A to Promote β-Oxidation in HepG2 Cells
   Chiao-Wei Lin et al, 2020, Molecules CrossRef
4. Cpt1a promoted ROS-induced oxidative stress and inflammation in liver injury via the Nrf2/HO-1 and NLRP3 inflammasome signaling pathway
   Xigang Luo et al, 2021, Canadian Journal of Physiology and Pharmacology CrossRef
5. Growth, biochemical indices and transcriptomic profile of Chinese mitten crab (Eriocheir sinensis) respond to different ratios of dietary carbohydrates to lipids
   Rantao Zuo et al, 2023, Frontiers in Marine Science CrossRef
6. Playing Jekyll and Hyde—The Dual Role of Lipids in Fatty Liver Disease
   Martijn R. Molenaar et al, 2020, Cells CrossRef
7. Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?
   Matteo Tacelli et al, 2018, Pharmaceuticals CrossRef